Cortellis Clinical Trials Intelligence

Clearly Cortellis

Highlights

  • Over 190,000 clinical trials
  • Drug, biomarker and device trials
  • Filtering for precision medicine
  • Best in class web portal

Intended for

  • Clinical Development Professional
  • Competitive Intelligence Professional
  • Information Professional

Description

Cortellis™ Clinical Trials Intelligence is the most powerful resource to accelerate clinical trial development decisions and portfolio strategy. Expertly curated clinical trials information is skillfully integrated with other scientific and competitive intelligence from Thomson Reuters. So you can make the most informed decision to direct your clinical strategies.

To find out more, visit go.thomsonreuters.com/cti

Features

Benefits

Trusted Global Intelligence

Find fast answers to critical questions in the right context - with contextual enrichment of clinical trials information through links to other scientific and competitive intelligence from Thomson Reuters:
  • Over 190,000 U.S. and global biomarker, device biologic and drug trials from thousands of sources. All indications including rare diseases.
  • More than 200,000 press releases indexed to clinical trial types or events. 2.25 million drug development articles.
  • Over 21,000 meetings abstracts and 8,000 conference reports. Optional transcripts of biomedical and medicinal chemistry industry analyst and investor meetings.
  • Medically trained researchers to assist verifying clinical trial information found in Cortellis Clinical Trials Intelligence.

Best-In-Class Technology

  • Powerful indexing with enhanced searching and filtering options to retrieve and analyze information by drug class, technology, disease therapy, and more.
  • Robust exporting capability.
  • Customizable views and alerting options.

Dynamic Analytic Tools

  • View distribution of indication, intervention, sponsor, phase, recruitment status, country design, and active control.
  • Fast insight into trial timelines  including a longitudinal view of trial start dates, insights on trial duration trends, and expected, actual, or projected end dates for a given indication, company, or individual drug.
  • Save visualizations in PowerPoint so findings can be easily updated and shared with key stakeholders.
  • Our team of experts can customize analytics and reporting to meet your unique business challenges.

Flexible Access & Integration

  • Access all clinical, competitive and scientific content from the iPad compatible Cortellis web portal.
  • Integrate content into other applications and  platforms in real-time through a suite of APIs (Application Programming Interfaces).
  • Incorporate your proprietary content and custom annotations  through our Integration Solutions.

Cortellis Clinical Trials Intelligence demo
Accelerate your strategic decision making with the industry's most powerful resource of clinical trials.

CLINICAL TRIALS ARTICLE

Assessing Drug Safety in Clinical Trials

Leveraging analytics to answer common questions about drug safety across classes of drugs or competing drug candidates.

White Paper

Overcoming Clinical Challenges in a BRIC market

Navigating clinical trials in emerging markets and BRIC nations, the challenges and benefits

PHARMA MATTERS REPORT

Developments in Clinical Trials

Utilizing various adaptive trial designs, regulating clinical trial transparency as well as therapeutic alternatives that are becoming available for patients.

  • From a purely scientific standpoint, the news about the Ebola outbreak has been encouraging bit.ly/11LzKyP

    1d 0 0

  • True healthcare reform has to take us from reactive care to proactive care bit.ly/11LbI7h

    1d 0 0

  • Ironwood receives $15m milestone from Astellas for 1st phase III enrollment of linaclotide against IBD with constipation

    2d 0 0

  • Visit Twitter
  • Alvaro Arjona

    Editorial and Content Manager

Download Fact Sheet

Fact Sheets